Passage BIO, Inc. — Director's Dealing 2021

Jun 10, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Passage BIO, Inc. (PASG)
CIK: 0001787297
Period of Report: 2021-05-30

Reporting Person: Burkavage Brian (Controller)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$22.63	2030-07-14	Common Stock (24000)		Direct
Employee Stock Option (Right to Buy)	$21.85	2031-02-15	Common Stock (6829)		Direct

Footnotes

F1: The stock option vested as to 25% of the total shares on July 15, 2021, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F2: The stock option vests as to 25% of the total shares on February 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.